Medawar, G., Warrick, M., Ritchie, J., Baratam, P. (2025). High-intensity purine analogue-based therapy for refractory/relapsed Acute Myeloid Leukemia (RR-AML): A single-institution experience. Blood. https://doi.org/10.1182/blood-2025-6986